Clinical Trials Directory

Trials / Sponsors / AOP Orphan Pharmaceuticals AG

AOP Orphan Pharmaceuticals AG

Industry · 15 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationA Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary
Pulmonary Arterial Hypertension
—2024-07-31
RecruitingInvestigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH
Pulmonary Arterial Hypertension
Phase 32024-07-31
RecruitingInitial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patient
Pulmonary Arterial Hypertension
Phase 42023-12-06
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients
Essential Thrombocythaemia
Phase 32023-12-04
CompletedStudy to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Ve
Polycythemia Vera
Phase 32015-07-01
CompletedAOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.
Polycythemia Vera
Phase 32014-11-01
CompletedAnagrelide Retard in Essential Thrombocythemia
Essential Thrombocythemia
Phase 32014-02-01
CompletedPegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera
Polycythemia Vera
Phase 32013-09-01
CompletedLong-term PK and Safety/Tolerability Testing LDLL600 Against Esmolol in Healthy Volunteers
Healthy
Phase 12012-12-01
CompletedA Pharmacokinetic, Pharmacodynamic, Safety Study With AOP LDLA202, ONO LDL50 and Esmolol in Healthy Volunteers
Healthy
Phase 12012-07-01
CompletedA Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol
Healthy Volunteers, Pharmacokinetics/Dynamics Study
Phase 22011-03-01
CompletedAnagrelide Retard vs. Placebo: Efficacy and Safety in "At-risk" Patients With Essential Thrombocythaemia
Essential Thrombocythaemia
Phase 32010-12-01
CompletedSafety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera
Polycythemia Vera
Phase 1 / Phase 22010-08-01
CompletedLancovutide (Moli1901) Inhalation Solution Study in Adolescents and Adults With Cystic Fibrosis
Cystic Fibrosis
Phase 22007-10-01
CompletedAnagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia
Essential Thrombocythaemia
Phase 32002-09-01